Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis
暂无分享,去创建一个
[1] M. Saegusa,et al. Down‐regulation of bcl‐2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas , 1997, The Journal of pathology.
[2] Q. Gao,et al. Progesterone induces apoptosis and up‐regulation of p53 expression in human ovarian carcinoma cell lines , 1997, Cancer.
[3] F. Montz,et al. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women , 1997, Cancer.
[4] M. Saegusa,et al. Bcl‐2 EXPRESSION IS CORRELATED WITH A LOW APOPTOTIC INDEX AND ASSOCIATED WITH PROGESTERONE RECEPTOR IMMUNOREACTIVITY IN ENDOMETRIAL CARCINOMAS , 1996, The Journal of pathology.
[5] M. Saegusa,et al. Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma. , 1996, Journal of clinical pathology.
[6] C. Cohen,et al. Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy , 1995, Cancer.
[7] M. Saegusa,et al. Apoptosis in Gastric Carcinomas and Its Association with Cell Proliferation and Differentiation , 1995, Japanese journal of cancer research : Gann.
[8] T. Arai,et al. Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas , 1995, The Journal of pathology.
[9] G. Núñez,et al. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. , 1995, The American journal of pathology.
[10] J. Crawford,et al. Ultrastructural localization of a fluorinated bile salt in hepatocytes. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[11] C. Winterford,et al. Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.
[12] S. Thorpe,et al. Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: Correlations with stage and other clinicopathologic features , 1993, American journal of obstetrics and gynecology.
[13] J. Isaacs,et al. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice. , 1992, Cancer research.
[14] G. Sutton,et al. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. , 1988, American journal of obstetrics and gynecology.
[15] L. Gerschenson,et al. Evidence for soluble factors regulating cell death and cell proliferation in primary cultures of rabbit endometrial cells grown on collagen. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Mccarty,et al. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. , 1985, American journal of obstetrics and gynecology.
[17] L. Gerschenson,et al. Estrogen and progesterone regulation of proliferation, migration, and loss in different target cells of rabbit uterine epithelium. , 1984, Endocrinology.
[18] R. Lieberman,et al. Effect of progesterone and 17 beta-estradiol on the production of uteroglobin by cultured rabbit uterine epithelial cells. , 1983, Endocrinology.
[19] R. Brenner,et al. Hormonal control of apoptosis in hamster uterine luminal epithelium. , 1979, The American journal of anatomy.
[20] L. Gerschenson,et al. Hormonal regulation of proliferation in two populations of rabbit endometrial cells in culture. , 1979, Life sciences.
[21] E. C. Reifenstein. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate. , 1974, Gynecologic oncology.
[22] A. Currie,et al. Adrenocortical cell deletion: The role of ACTH , 1973, The Journal of pathology.
[23] J. Kerr,et al. Deletion of cells by apoptosis during castration-induced involution of the rat prostate , 1973, Virchows Archiv. B, Cell pathology.
[24] R. M. Kelley,et al. Progestational agents in the treatment of carcinoma of the endometrium. , 1961, The New England journal of medicine.
[25] R. Kistner. Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium , 1959, Cancer.
[26] John Calvin Reed,et al. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[27] O. F. Chepick. Morphological aspects of the hormone-induced pathomorphosis of endometrial carcinoma. , 1993, European journal of gynaecological oncology.
[28] Chepick Of. Morphological aspects of the hormone-induced pathomorphosis of endometrial carcinoma. , 1993 .
[29] D. Herbold,et al. The significance of squamous differentiation in endometrial carcinoma , 1988 .
[30] N. Davidson,et al. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. , 1991, Cancer research.
[31] N. W. Elton. Morphologic Variations in Adenocarcinoma of the Fundus of the Uterus, with Reference to Secretory Activity and Clinical Interpretations , 1942 .